Get started
Author

N Behar

Observed names: Behar N, Behar, N, Nathalie Behar
Observed institutions: Inserm, Laboratoire Traitement du Signal et de l'Image, CIC Rennes, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Université de Rennes, University of Edinburgh
ORCID: 0000-0001-7529-8735
Observed ORCID: 0000-0001-7529-8735
OpenAlex ID: A5064943417
Controversy: in heart failure patients with a reduced ejection fraction and left bundle branch block, conduction system pacing can be a valid alternative to biventricular pacing—pro and contra
2025 · Haran Burri, Christophe Leclercq, et al. · EP Europace · 14
Development and external validation of the ‘Global Surgical-Site Infection’ (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery
2024 · McLean KA, Knight SR, et al. · British journal of surgery · 5
Phenotype heterogeneity of SCN5A mutations in Brugada syndrome
2024 · G Ribouleau, J B Gourraud, et al. · European Heart Journal · 2
PDF
Defibrillation testing during S-ICD implantation: How relevant? Results from a multicenter study
2023 · M Ben Kilani, P Jacon, et al. · EP Europace · 1
PDF
Learning curve in leadless pacemaker implantation: impact of center experience on procedure and fluoroscopy times in the france LEADLESS registry
2026 · E Marijon, S Boveda, et al. · EP Europace
Safety profile of a ventricular leadless pacemaker. Data from 1265 patients in the France LEADLESS study
2026 · P Defaye, S Boveda, et al. · EP Europace
Safety profile of ajmaline testing in Brugada syndrome: influence of SCNA5 mutations
2026 · N Drapier, J Gourraud, et al. · EP Europace
Leadless pacemaker implantation through the right internal jugular vein: primary results from the VAMPIRE prospective registry
2026 · P Ollitrault, A Mussigbrodt, et al. · EP Europace
Prognosis of Brugada patients according to their SCN5A genetic status
2026 · V Probst, P Petit, et al. · EP Europace
Comparison of baseline characteristics of population in france LEADLESS Registry and first ventricular leadless pacemaker implants in US
2026 · S Boveda, E Marijon, et al. · EP Europace
Phenotype heterogeneity of SCN5A mutations in Brugada syndrome
2026 · V Probst, G Ribouleau, et al. · EP Europace
Prognosis of asymptomatic patients who underwent a sodium channel blocker challenge
2026 · J Gourraud, P Petit, et al. · EP Europace
Early complications and long-term outcome of patients treated with a Subcutaneous Cardioverter-Defibrillator: temporal trends and clinical implications of the …
2026 · Donisi, L, Kerkouri, F, et al. · HAL
Preliminary results of the France LEADLESS study. A safety and effectiveness monitoring of a new ventricular leadless pacemaker
2025 · P Defaye, N Behar, et al. · EP Europace
PDF
one-year outcomes of the first 1000 patients implanted with th micra AV leadless pacing system in france: the AV-CESAR cohort study
2025 · F Kerkouri, N Clementy, et al. · EP Europace
PDF
How to better identify patients at high risk of inappropriate shocks before S-ICD implantation: Results from a multicenter experience
2022 · M Ben Kilani, P Jacon, et al. · EP Europace
PDF
P2279First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients
2019 · V Probst, G Clerici, et al. · European Heart Journal
Works count: 17
Citation count: 22
H-index: 2
I10-index: 1
Year
Topic
Type